160 filings
S-1/A
VVOS
Vivos Therapeutics Inc
IPO registration (amended)
19 Apr 24
7:52pm
S-1
VVOS
Vivos Therapeutics Inc
IPO registration
8 Apr 24
8:22pm
8-K
VVOS
Vivos Therapeutics Inc
28 Mar 24
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
8:38pm
10-K
2023 FY
VVOS
Vivos Therapeutics Inc
Annual report
28 Mar 24
4:23pm
8-K
VVOS
Vivos Therapeutics Inc
15 Feb 24
Entry into a Material Definitive Agreement
8:55am
SC 13G/A
VVOS
Vivos Therapeutics Inc
14 Feb 24
Vivos Therapeutics / Huntsman Ronald Kirk ownership change
5:42pm
SC 13G
Armistice Capital, LLC
14 Feb 24
Vivos Therapeutics / ARMISTICE CAPITAL ownership change
3:57pm
EFFECT
VVOS
Vivos Therapeutics Inc
4 Dec 23
Notice of effectiveness
12:15am
424B1
VVOS
Vivos Therapeutics Inc
1 Dec 23
Prospectus with pricing info
4:12pm
8-K
VVOS
Vivos Therapeutics Inc
30 Nov 23
Other Events
4:05pm
S-1/A
VVOS
Vivos Therapeutics Inc
IPO registration (amended)
30 Nov 23
4:03pm
CORRESP
VVOS
Vivos Therapeutics Inc
30 Nov 23
Correspondence with SEC
12:00am
UPLOAD
VVOS
Vivos Therapeutics Inc
30 Nov 23
Letter from SEC
12:00am
S-1
VVOS
Vivos Therapeutics Inc
IPO registration
22 Nov 23
4:46pm
10-Q
2023 Q3
VVOS
Vivos Therapeutics Inc
Quarterly report
14 Nov 23
12:00am
424B3
VVOS
Vivos Therapeutics Inc
3 Nov 23
Prospectus supplement
5:00pm
8-K
VVOS
Vivos Therapeutics Inc
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
VVOS
Vivos Therapeutics Inc
27 Oct 23
Material Modifications to Rights of Security Holders
4:15pm
8-K
VVOS
Vivos Therapeutics Inc
25 Sep 23
Submission of Matters to a Vote of Security Holders
9:00am
8-K
VVOS
Vivos Therapeutics Inc
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:10pm